{"id":"https://openalex.org/W4404733764","doi":"https://doi.org/10.1016/j.drudis.2024.104251","title":"Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?","display_name":"Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?","publication_year":2024,"publication_date":"2024-11-26","ids":{"openalex":"https://openalex.org/W4404733764","doi":"https://doi.org/10.1016/j.drudis.2024.104251","pmid":"https://pubmed.ncbi.nlm.nih.gov/39608486"},"language":"en","primary_location":{"id":"doi:10.1016/j.drudis.2024.104251","doi":"https://doi.org/10.1016/j.drudis.2024.104251","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.drudis.2024.104251","pdf_url":null,"source":{"id":"https://openalex.org/S152068293","display_name":"Drug Discovery Today","issn_l":"1359-6446","issn":["1359-6446","1878-5832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discovery Today","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.drudis.2024.104251","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036228687","display_name":"Lourens T. Bloem","orcid":"https://orcid.org/0000-0002-0014-8625","observed_orcids":["https://orcid.org/0000-0002-0014-8625"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Lourens T. Bloem","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Regulatory Science Network Netherlands, Utrecht, the Netherlands. Electronic address: l.t.bloem@uu.nl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Regulatory Science Network Netherlands, Utrecht, the Netherlands. Electronic address: l.t.bloem@uu.nl","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035747289","display_name":"Hubert G. M. Leufkens","orcid":"https://orcid.org/0000-0002-7175-1499","observed_orcids":["https://orcid.org/0000-0002-7175-1499"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hubert G.M. Leufkens","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010223613","display_name":"Sophie E. Berends","orcid":"https://orcid.org/0000-0002-3236-0698","observed_orcids":["https://orcid.org/0000-0002-3236-0698"]},"institutions":[{"id":"https://openalex.org/I4210133293","display_name":"Lygature","ror":"https://ror.org/02vtk3a57","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I4210133293"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sophie E. Berends","raw_affiliation_strings":["Regulatory Science Network Netherlands, Utrecht, the Netherlands; Lygature, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulatory Science Network Netherlands, Utrecht, the Netherlands; Lygature, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210133293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026358497","display_name":"Rick A. Vreman","orcid":"https://orcid.org/0000-0002-2076-322X","observed_orcids":["https://orcid.org/0000-0002-2076-322X"]},"institutions":[{"id":"https://openalex.org/I4210105140","display_name":"Roche (Netherlands)","ror":"https://ror.org/01gcg9888","country_code":"NL","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210105140"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Rick A. Vreman","raw_affiliation_strings":["Roche Netherlands B.V, Woerden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Netherlands B.V, Woerden, the Netherlands","institution_ids":["https://openalex.org/I4210105140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024669037","display_name":"Carla E. M. Hollak","orcid":"https://orcid.org/0000-0003-0464-1078","observed_orcids":["https://orcid.org/0000-0003-0464-1078"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Carla E.M. Hollak","raw_affiliation_strings":["Department of Endocrinology and Metabolism, Amsterdam UMC, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism, Amsterdam UMC, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I4210151833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008972062","display_name":"Sonja van Weely","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113026","display_name":"ZonMw, The Dutch Organisation for knowledge and innovation in health, healthcare and well-being","ror":"https://ror.org/01yaj9a77","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I4210113026"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sonja van Weely","raw_affiliation_strings":["ZonMw, The Hague, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ZonMw, The Hague, the Netherlands","institution_ids":["https://openalex.org/I4210113026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000715250","display_name":"Larissa M. de Lannoy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larissa M. de Lannoy","raw_affiliation_strings":["Independent Patient Advocate, Alphen aan den Rijn, the Netherlands","Independent patient advocate, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Independent Patient Advocate, Alphen aan den Rijn, the Netherlands","institution_ids":[]},{"raw_affiliation_string":"Independent patient advocate, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114814008","display_name":"Peter J A Bertens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J.A. Bertens","raw_affiliation_strings":["Association Innovative Medicines, The Hague, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Association Innovative Medicines, The Hague, the Netherlands","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032150304","display_name":"Anna M.G. Pasmooij","orcid":"https://orcid.org/0000-0003-0641-3829","observed_orcids":["https://orcid.org/0000-0003-0641-3829"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Anna M.G. Pasmooij","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Regulatory Science Network Netherlands, Utrecht, the Netherlands; Dutch Medicines Evaluation Board, Utrecht, the Netherlands. Electronic address: a.m.g.pasmooij@uu.nl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Regulatory Science Network Netherlands, Utrecht, the Netherlands; Dutch Medicines Evaluation Board, Utrecht, the Netherlands. Electronic address: a.m.g.pasmooij@uu.nl","institution_ids":["https://openalex.org/I193662353","https://openalex.org/I4210150351"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5032150304","https://openalex.org/A5036228687"],"corresponding_institution_ids":["https://openalex.org/I193662353","https://openalex.org/I4210150351"],"apc_list":{"value":4820,"currency":"USD","value_usd":4820},"apc_paid":{"value":4820,"currency":"USD","value_usd":4820},"fwci":0.8544,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.691,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"30","issue":"1","first_page":"104251","last_page":"104251"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/unmet-medical-needs","display_name":"unmet medical needs","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pharmaceutical-law","display_name":"pharmaceutical law","score":0.5540000200271606},{"id":"https://openalex.org/keywords/regulatory-science","display_name":"regulatory science","score":0.5260000228881836},{"id":"https://openalex.org/keywords/pharmaceutical-innovation","display_name":"pharmaceutical innovation","score":0.6079999804496765},{"id":"https://openalex.org/keywords/access-to-innovative-medicines","display_name":"access to innovative medicines","score":0.7540000081062317},{"id":"https://openalex.org/keywords/payers","display_name":"payers","score":0.40299999713897705},{"id":"https://openalex.org/keywords/stakeholder-engagement","display_name":"stakeholder engagement","score":0.734000027179718},{"id":"https://openalex.org/keywords/european-union","display_name":"European Union","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.6311333179473877},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.5383376479148865},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4602600038051605},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4119594097137451},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40779048204421997},{"id":"https://openalex.org/C55587333","wikidata":"https://www.wikidata.org/wiki/Q1133029","display_name":"Engineering ethics","level":1,"score":0.35945725440979004},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.3383744955062866},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.18172165751457214},{"id":"https://openalex.org/C155202549","wikidata":"https://www.wikidata.org/wiki/Q178803","display_name":"International trade","level":1,"score":0.17835935950279236},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.14019256830215454},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D005062","descriptor_name":"European Union","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006301","descriptor_name":"Health Services Needs and Demand","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.drudis.2024.104251","doi":"https://doi.org/10.1016/j.drudis.2024.104251","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.drudis.2024.104251","pdf_url":null,"source":{"id":"https://openalex.org/S152068293","display_name":"Drug Discovery Today","issn_l":"1359-6446","issn":["1359-6446","1878-5832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discovery Today","raw_type":"journal-article"},{"id":"pmid:39608486","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39608486","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug discovery today","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/f04e539d-1cea-4ac9-9df8-678f50d84a32","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/f04e539d-1cea-4ac9-9df8-678f50d84a32","pdf_url":"https://pure.amsterdamumc.nl/ws/files/143249170/Stimulating-development-of-innovative-medicines-in-the-european-union.pdf","source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Bloem, L T, Leufkens, H G M, Berends, S E, Vreman, R A, Hollak, C E M, van Weely, S, de Lannoy, L M, Bertens, P J A & Pasmooij, A M G 2025, 'Stimulating development of innovative medicines in the European Union : does a new definition for unmet medical need add value?', Drug discovery today, vol. 30, no. 1, 104251. https://doi.org/10.1016/j.drudis.2024.104251","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:oai:dspace.library.uu.nl:1874/474297","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/474297","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.drudis.2024.104251","doi":"https://doi.org/10.1016/j.drudis.2024.104251","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.drudis.2024.104251","pdf_url":null,"source":{"id":"https://openalex.org/S152068293","display_name":"Drug Discovery Today","issn_l":"1359-6446","issn":["1359-6446","1878-5832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discovery Today","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.4000000059604645,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4404733764.pdf","grobid_xml":"https://content.openalex.org/works/W4404733764.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W1965717563","https://openalex.org/W2771654639","https://openalex.org/W2897458944","https://openalex.org/W2900288872","https://openalex.org/W2971671169","https://openalex.org/W3128854106","https://openalex.org/W4317808907","https://openalex.org/W4385384941","https://openalex.org/W4386226057","https://openalex.org/W4399983602","https://openalex.org/W4406859020"],"related_works":["https://openalex.org/W4406128143","https://openalex.org/W4391727567","https://openalex.org/W7134236695","https://openalex.org/W4220836187","https://openalex.org/W7006058598","https://openalex.org/W4311334557","https://openalex.org/W4292688702","https://openalex.org/W4405749646","https://openalex.org/W4412658290","https://openalex.org/W7165761387"],"abstract_inverted_index":{"\u2022":[0,11,23,35,51],"The":[1,64],"2023":[2],"EU":[3],"pharmaceutical":[4,77],"legislation":[5],"proposal":[6],"redefines":[7],"\u2019unmet":[8],"medical":[9,38,73,142,153],"need\u2019":[10,74],"Flexibility,":[12],"feasibility,":[13,111],"fairness,":[14,112],"and":[15,79,85,88,113,135],"sensitivity":[16,114],"to":[17,49,58,61,70,75,83,115,182,186],"risk":[18],"are":[19],"not":[20,42,119],"fully":[21],"addressed.":[22,122],"A":[24,90,147],"more":[25,148],"high-level":[26,149],"definition":[27,82,150,185],"would":[28,129],"be":[29,130,180],"preferred":[30],"while":[31],"allowing":[32],"further":[33],"specification.":[34],"Redefining":[36],"unmet":[37,141,152],"need":[39,143,154],"alone":[40],"may":[41,144],"resolve":[43],"the":[44,53,81,94,101,133,166,173,184,188],"root":[45],"causes":[46],"of":[47,93,103,140,151],"barriers":[48],"innovation.":[50],"Narrowing":[52],"regulatory\u2013HTA/payer":[54],"gap":[55],"is":[56],"essential":[57,181],"improve":[59],"access":[60],"innovative":[62],"medicines.":[63],"European":[65],"Commission":[66],"(EC)":[67],"has":[68],"proposed":[69],"redefine":[71],"\u2018unmet":[72],"steer":[76],"innovation":[78,128],"link":[80],"incentives":[84],"regulatory":[86],"tools":[87],"procedures.":[89],"multistakeholder":[91],"meeting":[92],"Regulatory":[95],"Science":[96],"Network":[97],"Netherlands":[98],"(RSNN)":[99],"discussed":[100],"impact":[102],"this":[104],"proposal.":[105],"Four":[106],"principles":[107],"were":[108,118,124],"highlighted":[109],"(flexibility,":[110],"risk)":[116],"that":[117,155],"considered":[120],"sufficiently":[121],"Concerns":[123],"raised":[125],"about":[126],"whether":[127],"incentivised,":[131],"given":[132],"diverse":[134],"complex":[136],"reasons":[137],"why":[138],"areas":[139],"remain":[145],"unaddressed.":[146],"gives":[156],"guidance":[157],"but":[158],"allows":[159],"for":[160,162],"specification":[161],"specific":[163],"uses":[164],"throughout":[165],"medicine":[167],"lifecycle":[168],"was":[169],"generally":[170],"preferred.":[171],"As":[172],"legislative":[174],"process":[175],"unfolds,":[176],"stakeholder":[177],"engagement":[178],"will":[179],"refine":[183],"achieve":[187],"intended":[189],"policy":[190],"goals.":[191]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-11-27T00:00:00"}